Dorsey Wright & Associates’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-309
Closed -$15K 331
2020
Q3
$15K Sell
309
-158
-34% -$6.4K ﹤0.01% 164
2020
Q2
$15K Hold
467
﹤0.01% 181
2020
Q1
$8K Buy
+467
New +$8.18K ﹤0.01% 182
2019
Q3
Sell
-798
Closed -$15K 297
2019
Q2
$15K Buy
+798
New +$12.7K ﹤0.01% 172
2019
Q1
Sell
-1,230
Closed -$14K 296
2018
Q4
$14K Buy
1,230
+205
+20% +$2.23K ﹤0.01% 208
2018
Q3
$13K Buy
+1,025
New +$14.6K ﹤0.01% 247

Other funds holding CYRX

Dorsey Wright & Associates's CYRX Position: Q4 2020 in Review

Dorsey Wright & Associates sold out of CryoPort (CYRX) in Q4 2020, closing a stake of 309 shares — an estimated $15K sold.

Dorsey Wright & Associates first reported a position in CYRX in Q3 2018 and held it in 6 quarters. The position peaked at $15K in Q3 2020. 203 funds tracked by Wall St. Rank hold CYRX as of Q4 2020.

  • Dorsey Wright & Associates reported no remaining CryoPort position as of Q4 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 309 CryoPort shares in Q4 2020, an estimated $15K.
  • Dorsey Wright & Associates first reported a position in CryoPort in Q3 2018 and held it in 6 quarters.
  • Dorsey Wright & Associates's CryoPort position peaked at $15K in Q3 2020.
  • 203 funds tracked by Wall St. Rank held CryoPort as of Q4 2020.

Based on Dorsey Wright & Associates's 13F filing for Q4 2020, filed 28 Jan 2021.